Highlights From the American Diabetes Association Scientific Session 2023
JAMA Medical News12 Juli 2023

Highlights From the American Diabetes Association Scientific Session 2023

Data on a new crop of hormone analogues for weight loss—including an oral version of semaglutide and the triple agent retatrutide—were recently presented at the American Diabetes Association's annual Scientific Sessions. Robert Gabbay, MD, PhD, the ADA's chief scientific and medical officer, speaks with JAMA's Jennifer Abbasi about this and other clinical data presented at the meeting.

Related Content:

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(293)

The First CKM Syndrome Guidelines Are Here

The First CKM Syndrome Guidelines Are Here

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What to Know About the First CKM Syndrome Guidelines." Related Content: What to Know About the First...

17 Juli 5min

The Testosterone Therapy Debate

The Testosterone Therapy Debate

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Therapy: Does New Evidence Warrant Broader Prescribing?" Related Content: Testosterone ...

10 Juli 5min

Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected

Alzheimer Disease Blood Test May Have Higher Rate of False Positives Than Expected

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "First Alzheimer Disease Blood Test May Produce Many False-Positive Results, Study Finds." ...

2 Juli 5min

PMOS is the New PCOS

PMOS is the New PCOS

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "PCOS is Now PMOS—Will a New Name Translate to Improved Clinical Care?" Related Content: PCOS Is Now ...

26 Juni 5min

New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semagluti...

18 Juni 22min

Why Exercise Still Matters in the GLP-1 Drug Era

Why Exercise Still Matters in the GLP-1 Drug Era

JAMA Medical News Director Jennifer Abbasi and Staff Writer Samantha Anderer discuss "In Obesity Treatment, Physical Activity's Benefits Go Beyond Weight Loss, Says AHA." Related Content: In Obesity...

18 Juni 4min

The Search for a Fentanyl Vaccine

The Search for a Fentanyl Vaccine

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Inside the Push for a Fentanyl Vaccine." Related Content: Inside the Push for a Fentanyl Vaccine

12 Juni 5min

New Insights on HFpEF in Patients With Severe Obesity

New Insights on HFpEF in Patients With Severe Obesity

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "HFpEF May Be a Different Disease in Patients With Severe Obesity." Related Content: HFpEF May Be a D...

5 Juni 4min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
hacka-livet
rss-ufobortom-rimligt-tvivel
sexet
svd-nyhetsartiklar
medicinvetarna
det-morka-psyket
rss-vetenskapsradion
4health-med-anna-sparre
rss-spraket
bildningspodden
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
rss-ronden
paranormalt-med-caroline-giertz
psykopatpodden
dumforklarat
rss-broccolipodden-en-podcast-som-inte-handlar-om-broccoli
kvalificerat-hemligt-poddradio